These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 32019869)
1. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches. Hebert JD; Myers SA; Naba A; Abbruzzese G; Lamar JM; Carr SA; Hynes RO Cancer Res; 2020 Apr; 80(7):1475-1485. PubMed ID: 32019869 [TBL] [Abstract][Full Text] [Related]
2. Brain malignancies: Glioblastoma and brain metastases. Lah TT; Novak M; Breznik B Semin Cancer Biol; 2020 Feb; 60():262-273. PubMed ID: 31654711 [TBL] [Abstract][Full Text] [Related]
3. Separation of breast cancer and organ microenvironment transcriptomes in metastases. Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919 [TBL] [Abstract][Full Text] [Related]
4. Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases. Jailkhani N; Clauser KR; Mak HH; Rickelt S; Tian C; Whittaker CA; Tanabe KK; Purdy SR; Carr SA; Hynes RO Cancer Res; 2023 Jun; 83(12):2052-2065. PubMed ID: 37098922 [TBL] [Abstract][Full Text] [Related]
5. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles. Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142 [TBL] [Abstract][Full Text] [Related]
6. Impact of breast cancer cells´ secretome on the brain metastatic niche remodeling. Carvalho R; Paredes J; Ribeiro AS Semin Cancer Biol; 2020 Feb; 60():294-301. PubMed ID: 31711993 [TBL] [Abstract][Full Text] [Related]
8. The metastatic niche and stromal progression. Sleeman JP Cancer Metastasis Rev; 2012 Dec; 31(3-4):429-40. PubMed ID: 22699312 [TBL] [Abstract][Full Text] [Related]
9. Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer. Razmara AM; Sollier E; Kisirkoi GN; Baker SW; Bellon MB; McMillan A; Lemaire CA; Ramani VC; Jeffrey SS; Casey KM Clin Exp Metastasis; 2020 Jun; 37(3):413-424. PubMed ID: 32335861 [TBL] [Abstract][Full Text] [Related]
10. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816 [TBL] [Abstract][Full Text] [Related]
11. Lung metastases share common immune features regardless of primary tumor origin. García-Mulero S; Alonso MH; Pardo J; Santos C; Sanjuan X; Salazar R; Moreno V; Piulats JM; Sanz-Pamplona R J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32591432 [TBL] [Abstract][Full Text] [Related]
12. The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study. Hunt AL; Khan I; Wu AML; Makohon-Moore SC; Hood BL; Conrads KA; Abulez T; Ogata J; Mitchell D; Gist G; Oliver J; Wei D; Chung MA; Rahman S; Bateman NW; Zhang W; Conrads TP; Steeg PS Clin Exp Metastasis; 2024 Jun; 41(3):229-249. PubMed ID: 37917186 [TBL] [Abstract][Full Text] [Related]
13. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression. Cui D; Huang Z; Liu Y; Ouyang G Cell Mol Life Sci; 2017 Dec; 74(23):4287-4291. PubMed ID: 28884337 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis. Gu Y; Wu G; Zou X; Huang P; Yi L Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484 [TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. Naba A; Clauser KR; Whittaker CA; Carr SA; Tanabe KK; Hynes RO BMC Cancer; 2014 Jul; 14():518. PubMed ID: 25037231 [TBL] [Abstract][Full Text] [Related]
16. A glitch in the matrix: organ-specific matrisomes in metastatic niches. Deasy SK; Erez N Trends Cell Biol; 2022 Feb; 32(2):110-123. PubMed ID: 34479765 [TBL] [Abstract][Full Text] [Related]
17. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Gao D; Joshi N; Choi H; Ryu S; Hahn M; Catena R; Sadik H; Argani P; Wagner P; Vahdat LT; Port JL; Stiles B; Sukumar S; Altorki NK; Rafii S; Mittal V Cancer Res; 2012 Mar; 72(6):1384-94. PubMed ID: 22282653 [TBL] [Abstract][Full Text] [Related]
18. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Mehner C; Hockla A; Miller E; Ran S; Radisky DC; Radisky ES Oncotarget; 2014 May; 5(9):2736-49. PubMed ID: 24811362 [TBL] [Abstract][Full Text] [Related]
19. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors. Lescarbeau RM; Seib FP; Prewitz M; Werner C; Kaplan DL PLoS One; 2012; 7(8):e40372. PubMed ID: 22870197 [TBL] [Abstract][Full Text] [Related]
20. FGF13 promotes metastasis of triple-negative breast cancer. Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]